Skip to Content

GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)

Generic Name: sofosbuvir/velpatasvir

Pill with imprint GSI 7916 is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is supplied by Gilead Sciences, Inc..

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7916

Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916

Epclusa

Generic Name
sofosbuvir/velpatasvir
Imprint
GSI 7916
Strength
sofosbuvir 400 mg / velpatasvir 100 mg
Color
Pink
Size
20.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-2201
Inactive Ingredients
alcohol, copovidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, water, titanium dioxide, polyethylene glycol 3350, magnesium silicate, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.